Welcome to Scribd. Sign in or start your free trial to enjoy unlimited e-books, audiobooks & documents.Find out more
Standard view
Full view
of .
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
Emerging Trends in the Global Pharma Market

Emerging Trends in the Global Pharma Market

Ratings: (0)|Views: 1,998|Likes:
Published by Dr Amit Rangnekar

More info:

Published by: Dr Amit Rangnekar on Oct 09, 2008
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as DOC or read online from Scribd
See more
See less


Pharma Trends …
Emerging Trends in the World Pharmaceutical Industry
Amit Rangnekar 
PhD Programme-2004Narsee Monjee Institute of Management Studies (NMIMS)
Pharma Trends …
Executive Summary
 As the young age faster and the old stay younger, the women’s health segment emerges stronger. These key segments are driving the demand for lifestyle and lifecycle drugs. Dwindling growth rates, reduced margins and drug safety concerns are fuelling a raging debate in the pharma world over the effectiveness and productivity of exorbitant R&D spend. Patent management remains a key area to protect the near total sales erosion of blockbuster drugs post expiry.Mounting litigation costs are not deterring companies from developing countries to vie for a share of the lucrativeworld pharma market through generics and contract manufacturing. Amid this backdrop, India prepares for the shake out of the Post-2005 patent regime. Can India shed its copycat image and leverage its adroit intellectual capital and famed reverse engineering skills to finally emerge as amajor global hub in R&D, formulations, bulk actives and intermediates.
Pharma Trends …
Key certainties and their impact
Market Shifts
The frenetic pace of life, stressful and sedentary lifestyles coupled with junk food and irregular eatinghabits are triggering worldwide demand for a variety of chronic (long term) therapies like CentralNervous System (CNS), Cardiovascular and Diabetes drugs. Sales of hypertension, cholesterol,depression, anxiety, diabetes, obesity and sexual dysfunction drugs are booming.Worldwide, chronic therapies like Cardiovascular, CNS, Diabetes & Nutritional drugs contribute to morethan 65% of the market. In India, acute (short term) therapies like pain, infections, cough, cold & fever drugs contribute to 73% of the market while chronic therapies contribute only 27%. Anti-Infectivesaccount for 27% of the total Indian Pharma market
.However there is a perceptible shift towardschronic therapies in India with Diabetes, CV & CNS drugs registering robust growth
. The future bodeswell for companies focusing on these segments.The impact of these changes is felt in the vulnerability of the younger age groups to serious disorders.The age group vulnerable to cardiovascular, diabetic, psychotropic & sexual dysfunction disorders hasreduced from 60+ years in the 1970s, to 50+ in the 1980s to 40+ in the 1990s to 30+ today
. Everysixth diabetic in the world is an Indian today, but by 2030, every second diabetic is going to be Indian asthe Indian diabetic population is set to explode from 32 Million in 2003 to 81 Million in 2030
.On a contrary note, better healthcare facilities and medicines have led to increased life expectancylevels worldwide (India 64 years). This has spawned a growing geriatric (Age >55 years) market
Lifestyle Segment-Leading players (
)Lifestyle SegmentWorlds Leading Players
ObesityAbbott, SanofiCardiovascularPfizer, MerckDiabetesAventis, PfizePsychotropics (CNS)Lilly, GSKUlcersAstraZeneca, AbbottSexual DysfunctionPfizer, Lilly, GSK
e v ronc erapy
Source- ORG IMS 

Activity (9)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
giteganesh liked this
Nikhil Kasat liked this
Nikhil Kasat liked this
Neelesh Bhandari liked this
kharemix liked this
Ajay Verma liked this

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->